Alcohol and cardiovascular disease in the geriatric population

Aditi Kalla1, Vincent M Figueredo1,2

  • 1Institute for Heart & Vascular Health, Division of Cardiology, Einstein Medical Center, Philadelphia, Pennsylvania.

Clinical Cardiology
|March 16, 2017
PubMed

Insights

Moderate alcohol consumption shows no harm and potential cardiovascular benefits for older adults. However, heavy drinking increases risks of heart failure and hypertension in this age group.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Limited research exists on alcohol's impact on the elderly population.
  • Alcohol consumption and heavy episodic drinking have increased in US adults aged 65+.
  • Both potential cardiovascular benefits and risks of alcohol abuse are significant in older adults.

Purpose of the Study:

  • To review existing data on alcohol consumption and cardiovascular outcomes in older adults.
  • To examine effects on heart failure, hypertension, arrhythmias, and vascular function.
  • To differentiate impacts of moderate versus heavy alcohol use in the elderly.

Main Methods:

  • Systematic review of available data on alcohol consumption in adults aged 65 and older.
  • Analysis of studies focusing on cardiovascular disease, cardiomyopathy, arrhythmias, hypertension, and vascular function.
  • Evaluation of epidemiological data and clinical findings related to alcohol intake patterns.

Main Results:

  • Moderate alcohol consumption in older adults does not elevate risks for heart failure, hypertension, or atrial arrhythmias.
  • Moderate intake may enhance vascular function and decrease cardiovascular disease events in the elderly.
  • Heavy alcohol consumption or abuse negates protective effects, increasing heart failure and hypertension incidence.

Conclusions:

  • Moderate alcohol intake appears safe and potentially beneficial for cardiovascular health in the elderly.
  • Heavy alcohol consumption poses significant cardiovascular risks, including exacerbating hypertension and increasing heart failure.
  • Further research is needed to fully understand alcohol's complex role in geriatric cardiovascular health.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
294
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
334
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
306
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
771
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
294